MIST
Milestone Pharmaceuticals In
NASDAQ · Pharmaceuticals
$1.76
+0.04 (+2.33%)
Open$1.75
Previous Close$1.72
Day High$1.80
Day Low$1.75
52W High$46.68
52W Low$25.03
Volume—
Avg Volume98.6K
Market Cap149.90M
P/E Ratio22.20
EPS$1.61
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+2,481.3% upside
Current
$1.76
$1.76
Target
$45.43
$45.43
$30.70
$45.43 avg
$53.70
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.43M | 19.07M | 23.97M |
| Net Income | 7.18M | 5.86M | 8.22M |
| Profit Margin | 33.5% | 30.7% | 34.3% |
| EBITDA | 12.24M | 12.52M | 14.11M |
| Free Cash Flow | 4.04M | 4.46M | 4.28M |
| Rev Growth | +15.6% | +19.4% | -5.5% |
| Debt/Equity | 0.51 | 0.56 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |